Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.7 USD | -1.14% | -1.97% | -14.60% |
May. 01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.60% | 89.62B | |
+30.36% | 699B | |
+25.07% | 571B | |
-4.50% | 364B | |
+18.24% | 326B | |
+3.63% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.56% | 154B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Societe Generale Downgrades Bristol-Myers Squibb to Hold From Buy, Cuts Price Target to $51 From $85